PATENT CLAIM ANALYSIS

Application Number: 16096830
Application Type: Utility
Filing Date: 2018-10
Publication Date: 2019-05
Patent Classification: ["548", "950000"]

Abstract:
Pharmaceutical compositions of the invention comprise compounds, compositions, methods useful for the treatment of drug addiction, drug withdrawal, and diseases or conditions that involve dysregulation of glutamate homeostasis in its etiology.

Claim (Index 30):
The method of  claim 29 , wherein the disease that involves dysregulation of glutamate homeostasis is amyotrophic lateral sclerosis, malignant glioma, glioblastomas or glioblastoma multiforme.

Metadata:
- Claim Count in Document: 107.0
- Percentile: 97.0
- Lexical Diversity: 1.28571
- Patent Class: 548.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14895681', '14781081', '14388175', '15873293', '14412050']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7276875435640807
- 35 USC 102 Novelty (BERT): 0.5444124814967104
- Combined Prediction Score: 0.7093600373573437
- Mean Citation Score: 304.931952
- Max Citation Score: 425.56122
- Similarity Product: 177.16192168658498

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test